Composition, form of production and packaging
? Powder for topical use 1 fl.
gelatin 2.5 mg
kanamycin (in the form of monosulfate) 75 mg
dry blood plasma of cattle 175 mg
2.5 g - bottles (10) - packs of cardboard.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2010.
PHARMACHOLOGIC EFFECT
Zhelplastan is an absorbent hemostatic agent for topical application. The drug accelerates the process of thrombosis at the site of application, has antibacterial activity, is absorbed in the tissues of the body.
INDICATIONS
- to achieve hemostasis and "gluing" of tissues, especially with extensive damages of the parenchymal organs (eg, liver, spleen, kidneys);
- with open musculoskeletal injuries.
DOSING MODE
Zheplastan is used topically. The bottle with the drug is opened immediately before use. Immediately after drainage of the bleeding wound surface, the powder is applied uniformly and pressed with a gauze cloth until the bleeding stops completely. If the thickness of the powder layer is insufficient, the surface of the surface may be incurvated blood. In this case, you should raise the gauze pad and add additional amount of the drug to the bleeding sites and then squeeze again. After the final stop of bleeding, the excess drug is removed. The dose of the drug depends on the intensity of bleeding and the area of ​​the wound surface. The maximum drug consumption per patient usually does not exceed 15 g, but it can be used in a larger dose.
SIDE EFFECT
Allergic reactions.
CONTRAINDICATIONS
- children's age till 18 years;
- congenital and acquired disorders of the blood coagulation system;
- Hypersensitivity to the components of the drug.
APPLICATION FOR CHILDREN
Contraindicated in children under 18 years.
SPECIAL INSTRUCTIONS
Zheplastan is available in sterile bottles. Use only undamaged packaging. Repeated sterilization is not possible.
The production of the drug uses raw materials from animals that have no bacterial, mycoplasmal, prion, and viral etiology, pathogenic to humans.
Do not use drugs that reduce blood clotting, while using Zhelplastan.
OVERDOSE
There are no reports of overdose cases. Since the content of active components is very small, cases of overdose with Zheplastan are virtually impossible.
DRUG INTERACTION
Interactions with other drugs have not been established.
TERMS OF RELEASE FROM PHARMACY
Without recipe.
TERMS AND CONDITIONS OF STORAGE
In a dry, protected from light place at a temperature of no higher than 25 В° C. Keep out of the reach of children. Shelf life - 3 years.
